Showing results (1241-1250 of 1,523) with videos related to

Sort By:
Pageof 153
JTO Clinical and Research Reports|February 19, 2024
Adjuvant Osimertinib in Patients With Stage IB to IIIA EGFR Mutation-Positive NSCLC After Complete Tumor Resection: ADAURA China Subgroup AnalysisJie Wang, Yi-Long Wu, Shun Lu, et al.
Nature Communications|November 28, 2025
A 0.18 cubic centimeter 3D meta-holographic zoom micro-projectorDi Wang, Qian Huang, Chao Liu, et al.
The Lancet. Respiratory Medicine|July 24, 2017
Icotinib versus whole-brain irradiation in patients with EGFR-mutant non-small-cell lung cancer and multiple brain metastases (BRAIN): a multicentre, phase 3, open-label, parallel, randomised controlled trialJin-Ji Yang, Caicun Zhou, Yisheng Huang, et al.
Journal of the National Cancer Institute|April 5, 2017
Gefitinib or Erlotinib vs Chemotherapy for EGFR Mutation-Positive Lung Cancer: Individual Patient Data Meta-Analysis of Overall SurvivalChee Khoon Lee, Lucy Davies, Yi-Long Wu, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 2, 2013
Epidermal growth factor receptor inhibition in lung cancer: status 2012Fred R Hirsch, Pasi A Jänne, Wilfried E Eberhardt, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 30, 2018
Phase II Study of Crizotinib in East Asian Patients With ROS1-Positive Advanced Non-Small-Cell Lung CancerYi-Long Wu, James Chih-Hsin Yang, Dong-Wan Kim, et al.
BMC Cancer|November 28, 2018
Crizotinib in advanced non-small-cell lung cancer with concomitant ALK rearrangement and c-Met overexpressionRui-Lian Chen, Jun Zhao, Xu-Chao Zhang, et al.
Clinical Lung Cancer|April 25, 2022
Safety of Tepotinib in Patients With MET Exon 14 Skipping NSCLC and Recommendations for ManagementRemi Veillon, Hiroshi Sakai, Xiuning Le, et al.
JAMA Network Open|August 13, 2021
Clinical Characteristics, Management, and In-Hospital Outcomes in Patients With Stroke or Transient Ischemic Attack in ChinaHong-Qiu Gu, Xin Yang, Chun-Juan Wang, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 15, 2022
Expert Consensus Recommendations on Biomarker Testing in Metastatic and Nonmetastatic NSCLC in AsiaTetsuya Mitsudomi, Daniel Tan, James Chih-Hsin Yang, et al.
Pageof 153